1
|
|
Chapter 1 Optimal Control Dynamics of Gonorrhea in a Structured Population
Joshua Kiddy K. Asamoah , Beilawu Safianu , Emmanuel Afrifa , Benjamin Obeng , Baba Seidu , Fredrick Asenso Wireko , Gui-Quan Sun
PDF (0 KB)
|
|
|
|
1
|
|
Chapter 2 Treatment of Bacterial Sexually Transmitted Infections in Europe: Gonorrhoea, Mycoplasma Genitalium, and Syphilis
Oriol Mitjà, Clara Suñer, Lorenzo Giacani,, Martí Vall-Mayans, George-Sorin Tiplica,Jonathan D. C. Ross,and Catriona S. Bradshawh
PDF (0 KB)
|
|
|
|
1
|
|
Chapter 3 At-Home Self-Collection of Urine or Vaginal Samples for Gonorrhea and Chlamydia Screening Among Young People Who Were Assigned Female at Birth
TanaChongsuwat,MD,MPH,PaulaJ.Cody,MD,MPH
PDF (0 KB)
|
|
|
|
1
|
|
Chapter 4 Resistance-minimising Strategies for Introducing a Novel Antibiotic for Gonorrhoea Treatment: a Mathematical Modelling Study
Resistance-minimising strategies for introducing a novel antibiotic for gonorrhoea treatment: a mathematical modelling study
PDF (0 KB)
|
|
|
|
1
|
|
Chapter 5 Kissing, Fellatio, and Analingus as Risk Factors for Oropharyngeal Gonorrhoea in Men Who Have Sex with Men: A Cross-sectional Study
Julien Tran, Jason J. Ong, Catriona S. Bradshaw, Marcus Y. Chen, Fabian Y.S. Kong,Jane S. Hocking, Ei T. Aung, Kate Maddaford, Christopher K. Fairley,and Eric P.F. Chow
PDF (0 KB)
|
|
|
|
1
|
|
Chapter 6 Public Health Impact and Cost-effectiveness of Gonorrhoea Vaccination: an Integrated Transmission-dynamic Health-economic Modelling Analysis
Lilith K Whittles, Xavier Didelot, Peter J White
PDF (0 KB)
|
|
|
|
1
|
|
Chapter 7 Mathematical Analysis of a Model for Chlamydia and Gonorrhea Codynamics with Optimal Control
E.C. Chukukere , A. Omamea, C.P. Onyenegecha , S.C. Inyama
PDF (0 KB)
|
|
|
|
1
|
|
Chapter 8 Impact of the COVID-19 Pandemic on Chlamydia and Gonorrhea Screening in the U.S.
Casey N. Pinto, PhD, MPH, NP-C, Justin K. Niles, MA, Harvey W. Kaufman, MD, Elizabeth M. Marlowe, PhD,Damian P. Alagia, MD, Guangqing Chi, PhD, Barbara Van Der Pol, PhD, MPH
PDF (0 KB)
|
|
|
|
1
|
|
Chapter 9 Ensuring Equity with Pre-clinical Planning for Chlamydia Vaccines
Amanda L. Collar , Tegan N. Clarke, Andzoa N. Jamus and Kathryn M. Frietze
PDF (0 KB)
|
|
|
|
1
|
|
Chapter 10 Chlamydia Trachomatis from Australian Aboriginal People with Trachoma are Polyphyletic Composed of Multiple Distinctive Lineages
Patiyan Andersson, Simon R. Harris, Helena M.B. Seth Smith, James Hadfield, Colette O’Neill, Lesley T. Cutcliffe5, Fiona P. Douglas1, L. Valerie Asche1, John D. Mathews1,6, Susan I. Hutton, Derek S. Sarovich, Steven Y.C. Tong, Ian N. Clarke, Nicholas R. Th
PDF (0 KB)
|
|
|
|
1
|
|
Chapter 11 Replication-dependent Size Reduction Precedes Differentiation in Chlamydia Trachomatis
Jennifer K. Lee , Germán A. Enciso, Daniela Boassa , Christopher N. Chander, Tracy H. Lou, Sean S. Pairawan, Melody C. Guo, Frederic Y.M. Wan, Mark H. Ellisman, Christine Sütterlin & Ming Tan
PDF (0 KB)
|
|
|
|
1
|
|
Chapter 12 Chlamydia Infection Depends on a Functional MDM2-p53 Axis
Erik Gonza´lez, Marion Rother, Markus C. Kerr, Munir A. Al-Zeer, Mohammad Abu-Lubad, Mirjana Kessler, Volker Brinkmann, Alexander Loewer& Thomas F. Meyer
PDF (0 KB)
|
|
|
|
1
|
|
Chapter 13 Chlamydia Trachomatis Serovars in Urogenital and Ocular Samples Collected 2014–2017 from Austrian Patients
Iwona Lesiak-Markowicz, Anna-Margarita Schötta, Hannes Stockinger, Gerold Stanek & Mateusz Markowicz
PDF (0 KB)
|
|
|
|
1
|
|
Chapter 14 Genetic and Phenotypic Analysis of the Pathogenic Potential of Two Novel Chlamydia Gallinacea Strains Compared to Chlamydia Psittaci
Marloes Heijne, Martina Jelocnik, Alexander Umanets, Michael S. M. Brouwer, Annemieke Dinkla, Frank Harders3, Lucien J. M. van Keulen3, Hendrik Jan Roest, Famke Schaafsma, Francisca C. Velkers, Jeanet A. van der Goot, Yvonne Pannekoek6& Ad P. Koets
PDF (0 KB)
|
|
|
|